Vertex Pharmaceuticals will not advance clinical trials of a treatment for Type 1 diabetes after efficacy data failed to support further clinical advancement.

Areas with elevated microplastic levels experience increased rates of hypertension, diabetes, stroke, and other ...

The rise of GLP-1s, which were initially approved for diabetes management and later for obesity treatment, underscores this ...

The recent federal cancellation of a 30-year-old study over a nonrelated dispute with the study coordinator, Columbia ...

Weight fluctuation was associated with a greater risk for diabetic kidney disease progression among individuals with type 1 diabetes.

The following is a summary of “Incorporating Complementary Therapies Into Diabetes Care,” published in the February 2025 issue of Journal of Clinical Endocrinology & Metabolism by Blanchette et al.

Once-a-weekly, prescription-based medicine, Mounjaro is a single molecule that selectively binds to and activates both GIP ...

US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, ...

A Victorian mum who was patient zero in a world-first trial that used an app to act as her artificial pancreas has spoken of how she believes it saved her life.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States and a ...

Adults with insulin-treated type 2 diabetes had greater HbA1c reductions and larger improvement in time in range with use of ...

Four years into the mutually negotiated 10-year contract between Diabeter, a type 1 diabetes mellitus care-integrated ...